IRVINE, Calif., Oct. 9, 2014 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, plans to
announce its operating results for the quarter ended September 30, 2014 after the market closes on
Thursday, October 23, 2014 and will
host a conference call at 5:00 p.m.
ET that day to discuss its results.
To participate in the conference call, dial (877) 407-8037 or
(201) 689-8037. For 72 hours following the call, an audio
replay can be accessed by dialing (877) 660-6853 or (201) 612-7415
and using conference number 13592286. The call will also be
available via live or archived webcast on the "Investor Relations"
section of the Edwards web site at ir.edwards.com. A live stream
and archived replay can also be accessed via mobile devices by
downloading Edwards' IR App for iPhone and iPad or
Android.
About Edwards Lifesciences
Edwards Lifesciences is the
global leader in the science of heart valves and hemodynamic
monitoring. Driven by a passion to help patients, the company
partners with clinicians to develop innovative technologies in the
areas of structural heart disease and critical care monitoring that
enable them to save and enhance lives. Additional company
information can be found at www.edwards.com.
Edwards is a trademark of Edwards Lifesciences
Corporation. Edwards Lifesciences and the stylized E logo are
trademarks of Edwards Lifesciences Corporation and are registered
in the United States Patent and
Trademark Office.
Logo -
http://photos.prnewswire.com/prnh/20140714/126903
SOURCE Edwards Lifesciences Corporation